Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.
You’re viewing a free company profile from the PitchBook Platform. To explore Ndzhentiks’s full profile, request a free trial.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.